[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334719-105":59,"doc-detail-334719-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","circulating-microbiome-dna-as-biomarkers-for-early-diagnosis-and-recurrence-of-lung-cancer-published-article","Circulating microbiome DNA as biomarkers for early diagnosis and recurrence of lung cancer - published article","","Chen and colleagues investigate whether circulating microbiome DNA (cmDNA) can serve as a diagnostic and prognostic biomarker in lung cancer. Whole-genome sequencing is applied to plasma from lung cancer patients and healthy controls to identify differentially enriched microbial species. A cmDNA-based diagnostic model achieves high sensitivity and accuracy, including detection of early-stage disease. A recurrence-focused model further predicts postoperative lung cancer recurrence, supporting a liquid-biopsy paradigm.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/circulating-microbiome-dna-as-biomarkers-for-early-diagnosis-and-recurrence-of-lung-cancer-published-article/334719/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/circulating-microbiome-dna-as-biomarkers-for-early-diagnosis-and-recurrence-of-lung-cancer-published-article/334719.png","ImageObject",300,407,{"name":92,"@type":93},"Ava Thompson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What does the study evaluate as potential biomarkers for lung cancer?","Question",{"text":113,"@type":114},"The study evaluates circulating microbiome DNA (cmDNA) in plasma as biomarkers for early diagnosis and postoperative recurrence of lung cancer.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How is the diagnostic model built and what performance is reported?",{"text":118,"@type":114},"Whole-genome sequencing identifies differentially enriched microbial species between lung cancer patients and healthy controls, and a diagnostic model is trained and validated, reporting high sensitivity and AUC in an independent validation dataset.",{"name":120,"@type":111,"acceptedAnswer":121},"Can cmDNA predict recurrence after surgery?",{"text":122,"@type":114},"Yes. The study constructs a cmDNA-based model for recurrence that precisely predicts lung cancer recurrence following surgery.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},334719,1790183276,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":36,"preview_page_count":4},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","Article  \nCirculating microbiome DNA as biomarkers for early diagnosis and recurrence of lung cancer  \nAuthors  \nHaiming Chen, Yi Ma, Juqing Xu, ..., Yiming Lu, Hao Wu, Mantang Qiu  \nCorrespondence  \n[ylu.phd@gmail.com](ylu.phd@gmail.com) (Y.L.),  \n[haowudr@hotmail.com](haowudr@hotmail.com) (H.W.),  \n[qiumantang@163.com](qiumantang@163.com) (M.Q.)  \nIn brief  \nChen et al. reveal that circulating microbiome DNA can be a biomarker for lung cancer diagnosis and recurrence, establishing a paradigm of cancer liquid biopsy.  \nd The cmNDA proﬁles of lung cancer patients exhibit unique characteristics  \nd A cmDNA-based diagnostic model of lung cancer exhibits high accuracy  \nd cmDNA can predict lung cancer recurrence after surgery  \nChen et al., 2024, Cell Reports Medicine 5, 101499  \nApril 16, 2024 ª 2024 The Authors. Published by Elsevier Inc.  \n[https://doi.org/10.1016/j.xcrm.2024.101499](https://doi.org/10.1016/j.xcrm.2024.101499)  \nll  \nll  \nOPEN ACCESS  \nArticle  \nCirculating microbiome DNA as biomarkers  \nfor early diagnosis and recurrence of lung cancer  \nHaiming Chen,1,2,3,8 Yi Ma,4,8 Juqing Xu,5 Wenxiang Wang,1,2,3 Hao Lu,6 Cheng Quan,6 Fan Yang,1,2,3 Yiming Lu,6,* Hao Wu,7,* and Mantang Qiu1,2,3,9,*  \n1Department of Thoracic Surgery, Peking University People’s Hospital, Beijing 100044, China  \n2Thoracic Oncology Institute, Peking University People’s Hospital, Beijing 100044, China  \n3Institute of Advanced Clinical Medicine, Peking University, Beijing 100191, China  \n4Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China  \n5Department of Hematology and Oncology, Geriatric Hospital of Nanjing Medical University, Nanjing 210009, China  \n6Beijing Institute of Radiation Medicine, State Key Laboratory of Proteomics, Beijing 100850, China  \n7Department of Thoracic Surgery, Shenzhen Second People’s Hospital, Shenzhen 518035, China  \n8These authors contributed equally  \n9Lead contact  \n*Correspondence: [ylu.phd@gmail.com](ylu.phd@gmail.com) (Y.L.), [haowudr@hotmail.com](haowudr@hotmail.com) (H.W.), [qiumantang@163.com](qiumantang@163.com) (M.Q.) [https://doi.org/10.1016/j.xcrm.2024.101499](https://doi.org/10.1016/j.xcrm.2024.101499)  \nSUMMARY  \nLung cancer mortality is exacerbated by late-stage diagnosis. Emerging evidence indicates the potential clinical signiﬁcance of distinct microbial signatures as diagnostic and prognostic biomarkers across various cancers. However, circulating microbiome DNA (cmDNA) proﬁles are underexplored in lung cancer (LC) . Here, whole-genome sequencing is performed on plasma of LC patients and healthy controls (HCs) . Differentially enriched microbial species are identiﬁed between LC and HC. A diagnostic model is developed, which has a high sensitivity of 87.7% and achieves an AUC of 93.2% in the independent validation dataset. Crucially, this model demonstrates the capability to detect early-stage LC, achieving a sensitivity of 86.5% for stage I and 87.1% for tumors \u003C1 cm. In addition, we construct acmDNA model for recurrence, which precisely predicts LC recurrence after surgery. Overall, this study highlights the signiﬁcant alterations of cmDNA proﬁles in LC, indicating its potential as biomarkers for early diagnosis and recurrence.  \nINTRODUCTION  \nLung cancer (LC) is the second most common cancer and the leading cause of cancer mortality worldwide.1 The prognosis of LC is signiﬁcantly associated with the stages at which cancer patients are diagnosed.2 If diagnosed early, the 5-year survival rate is >90%, but when diagnosed at the late metastatic stage, it drops to \u003C5% .2 Therefore, early detection is a critical strategy in reducing LC mortality rates. Unfortunately, >80% of LC cases are detected at an advanced stage, which contributes to the high mortality rates.3 Chest low-dose computed tomography screening has been demonstrated to reduce cancer-related deaths by 20% in large randomized trials4 ,5. However, given its unsatisfactory","cbCaisGEirtofmBg","https://ap.wps.com/l/cbCaisGEirtofmBg","pdf",3820837,16,"English","# Summary\n# Introduction\n## Clinical need for early lung cancer detection\n## Postoperative recurrence risk and prediction need\n## Role of lung microbiome in cancer development and prognosis","[{\"question\":\"What does the study evaluate as potential biomarkers for lung cancer?\",\"answer\":\"The study evaluates circulating microbiome DNA (cmDNA) in plasma as biomarkers for early diagnosis and postoperative recurrence of lung cancer.\"},{\"question\":\"How is the diagnostic model built and what performance is reported?\",\"answer\":\"Whole-genome sequencing identifies differentially enriched microbial species between lung cancer patients and healthy controls, and a diagnostic model is trained and validated, reporting high sensitivity and AUC in an independent validation dataset.\"},{\"question\":\"Can cmDNA predict recurrence after surgery?\",\"answer\":\"Yes. The study constructs a cmDNA-based model for recurrence that precisely predicts lung cancer recurrence following surgery.\"}]","Circulating microbiome DNA as biomarkers for early diagnosis and recurrence of lung cancer - published article | PDF",1790008016]